Home › Funds › Propel Bio Management, LLC › MIST

Propel Bio Management, LLC position in MIST

MILESTONE PHARMACEUTICALS IN · Health Care

Propel Bio Management, LLC reported holding 9,449,727 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q3 2026 13F filing — a position valued at US$8.2M, representing 4.34% of its reported portfolio and ranking #7 among its reported holdings. Propel Bio Management, LLC has disclosed MIST holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)9.45M sh
Reported value held$8.18M
Portfolio Weight4.34%
First reportedQ1 2025
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Propel Bio Management, LLC's MIST position evolved

Propel Bio Management, LLC first disclosed a stake in MIST in Q1 2025 at 1,451,557 shares (US$1.2M). The position peaked in Q3 2025 at 5,124,890 shares, worth US$10.2M. Across 7 filings, Propel Bio Management, LLC increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 9,449,727 shares valued at US$8.2M — an increase of 2,020,137 shares quarter over quarter.. Notable position changes include a 186% increase in Q3 2025 (shares rose 1% over the following quarter), a 80% increase in Q2 2026 (shares fell 35% over the following quarter), a 27% increase in Q3 2026 (shares fell 40% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 1.45M $1.16M New
Q2 2025 1.79M $3.48M Add
Q3 2025 5.12M $10.25M Add
Q4 2025 4.12M $8.32M Reduce
Q1 2026 4.12M $5.08M Hold
Q2 2026 7.43M $9.96M Add
Q3 2026 9.45M $8.18M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIST and 13F data

MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 29 other funds we track also report a position in MIST — the largest reported positions include Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$2.9M), Kalehua Capital Management LLC (US$1.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIST

All MIST fund holders →

FAQ

How long has Propel Bio Management, LLC held MIST?

Propel Bio Management, LLC has disclosed MIST holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Propel Bio Management, LLC's current position in MIST?

As of Q3 2026, Propel Bio Management, LLC holds 9.45M shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $8.18M, representing 4.34% of its reported portfolio and ranking #7.

Has Propel Bio Management, LLC been buying or selling MIST?

In the latest 13F filing (Q3 2026), Propel Bio Management, LLC increased its position in MIST. The position peaked in Q3 2025 at 5.12M shares.

Which other funds hold MIST?

Other major institutional holders of MIST include Pavaki Capital Management LLC, Simplify Asset Management Inc., Kalehua Capital Management LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.